A comparative study for the short-term effects of targeted high-intensity UVB and narrow-band UVB in the treatment of vitiligo
- PMID: 28587417
- PMCID: PMC5450568
- DOI: 10.3892/etm.2017.4381
A comparative study for the short-term effects of targeted high-intensity UVB and narrow-band UVB in the treatment of vitiligo
Abstract
Vitiligo is a common acquired depigmentation disorder for which many treatments have previously been used with varying effects. The aim of the present study was to evaluate the efficacy and safety of targeted high-intensity (TH) and narrow band (NB) ultraviolet B light (UVB) for vitiligo treatment. A total of 33 patients with vitiligo were enrolled in the present study. Patients with a symmetrical or near-symmetrical distribution of lesions on their bodies were selected for the present study. For each patient, half of the body was treated with TH-UVB and the other with NB-UVB twice weekly over a period of 12 weeks (24 times total). The patients were assessed each week for repigmentation of lesions. All data were analyzed using SPSS software, and a total of 30 patients were evaluated. The effective rate was significantly higher in the TH-UVB group (56.7%) compared with the NB-UVB group (20.0%; P<0.05). Additionally, the mean number of radiations necessary for initial repigmentation was significantly lower in the TH-UVB group (7.95±3.43) compared with the NB-UVB group (15.36±3.43; P<0.05). No correlation was found between the clinical features of patients and the efficacy of treatment. In summary, the results of the present study suggest that TH-UVB is a more effective treatment for vitiligo than NB-UVB.
Keywords: efficacy; ultraviolet; vitiligo.
Figures

Similar articles
-
Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo.J Dermatolog Treat. 2019 Nov;30(7):691-696. doi: 10.1080/09546634.2018.1544409. Epub 2018 Dec 5. J Dermatolog Treat. 2019. PMID: 30474443
-
Comparison of efficacy and safety profile of topical calcipotriol ointment in combination with NB-UVB vs. NB-UVB alone in the treatment of vitiligo: a 24-week prospective right-left comparative clinical trial.J Eur Acad Dermatol Venereol. 2015 May;29(5):925-32. doi: 10.1111/jdv.12726. Epub 2014 Sep 15. J Eur Acad Dermatol Venereol. 2015. PMID: 25220387 Clinical Trial.
-
Evaluation of using fractional CO2 laser plus NB-UVB versus NB-UVB alone in inducing marginal repigmentation of vitiligo lesions.J Dermatolog Treat. 2019 Nov;30(7):697-700. doi: 10.1080/09546634.2018.1564232. Epub 2019 Jun 19. J Dermatolog Treat. 2019. PMID: 30592235 Clinical Trial.
-
Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.Photodermatol Photoimmunol Photomed. 2017 Jan;33(1):22-31. doi: 10.1111/phpp.12277. Epub 2016 Nov 23. Photodermatol Photoimmunol Photomed. 2017. PMID: 27696531 Review.
-
What Is New in Narrow-Band Ultraviolet-B Therapy for Vitiligo?Indian Dermatol Online J. 2019 May-Jun;10(3):234-243. doi: 10.4103/idoj.IDOJ_310_18. Indian Dermatol Online J. 2019. PMID: 31149564 Free PMC article. Review.
Cited by
-
The efficacy of fractional carbon dioxide laser combined with narrow-band ultraviolet B phototherapy for non-segmental vitiligo: a systematic review and meta-analysis.Lasers Med Sci. 2021 Feb;36(1):165-173. doi: 10.1007/s10103-020-03069-0. Epub 2020 Jun 23. Lasers Med Sci. 2021. PMID: 32572662
-
Design and Implementation of a Heating Treatment System for Vitiligo Skin Disease Based on Medical Ultrasound.J Healthc Eng. 2021 Mar 9;2021:6634846. doi: 10.1155/2021/6634846. eCollection 2021. J Healthc Eng. 2021. Retraction in: J Healthc Eng. 2023 May 24;2023:9754043. doi: 10.1155/2023/9754043. PMID: 33777344 Free PMC article. Retracted.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources